Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

New China–Russia Trade Agreement China and Russia have upped their economic partnership with a new set of agreements. In late October 2025 Beijing and Moscow announced that they would “push for a stable expansion of two-way trade with an optimized structure” People. Commerce Minister Wang Wentao and Russia’s economic minister Reshetnikov co‑chaired a subcommittee meeting on Sept. 28, where they…
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Stock Performance & Chart Trend Oracle’s stock peaked at an all-time high around $345 in early Sept. 2025 (intraday) thanks to blockbuster AI/cloud news ts2.tech. In the past two weeks it has pulled back to the high-$200s: on Oct. 24 it traded in the $282–$287 range (closing at $285.72) ts2.tech, but by Oct. 30 it was around $270. This recent drop followed…
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Rockets to $5 Trillion Valuation – AI Frenzy Fuels Record Highs

Nvidia’s Santa Clara campus (headquarters). The company’s stock hit record highs this week as AI chip demand exploded, powering Nvidia to a historic $5 trillion market value Reuters Reuters. Record Highs and Stock Performance Nvidia shares extended a remarkable run this week. On Oct 29, the stock closed at about $207.04, up ~3% on the day, pushing its market capitalization…
Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

BYD’s Earnings Dive amid Fierce Price War BYD’s October 2025 report shocked investors: third-quarter profit plunged to ¥7.8 billion, down almost 33% from a year ago Investing. CEO Wang Chuanfu has slashed prices across BYD’s model range to fend off competition, triggering the rare profit drop. (In Q2 2025 BYD had already warned of a 30% net income drop ts2.tech.) Analysts…
Tesla’s Trillion-Dollar Gamble: Musk’s Epic Pay Deal Divides Investors – What You Need to Know

Tesla Stock Surges on Record Q3 Sales – Can It Keep Climbing?

Recent Trading and Market Context Tesla Inc. (NASDAQ: TSLA) shares have been trading near the top of their 52-week range amid the late-October market rally. After rising to new highs earlier in October (briefly touching the mid-$450s on Oct. 6), the stock consolidated in the low- to mid-$440s by Oct. 30 ts2.tech ts2.tech. On Monday Oct. 27, TSLA jumped about 4.3% – its…
BYD’s European EV Invasion – Boom in Sales but Stock Takes a Hit

BYD Stock Plunges 30% on Profit Slump – Is the EV Price War to Blame?

BYD Shares: Price and Recent Moves BYD’s stock has experienced a sharp correction in recent months. In early 2025 the Hong Kong-listed shares hit record highs (above HK$150 in May), but by late October they traded near HK$104 Reuters – roughly 30% below the peak Bloomberg. This slide erased tens of billions in market value. For example, Bloomberg reports the…
Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Bidding War Sends Metsera Shares Higher Metsera’s share price has been on a roller-coaster amid takeover speculation. In late September, Pfizer agreed to buy Metsera for $47.50 per share in cash (about $4.9B) plus up to $22.50 in contingent payments Sec. Pfizer CEO Albert Bourla said this deal “propels Pfizer into this key therapeutic area” of obesity treatment Sec. Metsera…
Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Inc. (Nasdaq: BIIB) is a leading neuroscience biotech known for multiple sclerosis and rare-disease therapies ts2.tech. On Oct. 30, 2025 the stock dipped after a mixed earnings release. The company beat Q3 expectations – adjusted EPS $4.81 vs. $3.88 est and $2.53 B revenue vs. $2.34 B est Investing – but lowered its full-year outlook. Biogen now expects 2025 non-GAAP EPS…
GLE Stock Skyrockets 50%: Key Facts & What’s Next

GLE Stock Skyrockets 50%: Key Facts & What’s Next

Market context: Hong Kong’s stock market has been booming in 2025 (Hang Seng +35% YTD) ts2.tech. GLE’s recent spike (circled) comes against a broad tech rally, but its own financials remain thin. Trading Rundown (Last Few Days) In late Oct 2025, GLE’s stock was trading in the $0.62–0.70 range Stockanalysis. On Oct 29 it closed at $0.6526 Stockanalysis (up ~3.2%…
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

CI Stock Price and Recent Trend Cigna’s stock has pulled back modestly in late October after a strong run earlier in the year. According to market data, CI closed at $299.12 on Oct 29, 2025, down about 3% from the previous close Stockanalysis. The dip followed weakness in broader managed-care stocks amid concerns about healthcare costs and policy. In pre-market…
Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

Stock Performance Today Estée Lauder shares jumped in early trading after the earnings release. Reuters data show EL pre-market up ~5% to $102.26 Tradingview. By midday Oct. 30 the stock was about $97.36, down ~1.4% on the day Reuters. (Over the past six months, the stock has rallied roughly 60% amid optimism about a rebound in China and travel retail…
30 October 2025
Hot GDP Surprise Shatters Wall Street’s Rally – Stocks Slide on Fed Jitters (Sept 25, 2025)

Stock Market Rollercoaster: Tech Stocks Tumble After Trump-Xi Trade Truce & Fed’s Hawkish Signals

Market Recap Global stocks wobbled this week on the twin shocks of trade news and monetary policy. In Busan on Oct. 30, Trump met Xi Jinping and touted a deal to trim U.S.–China tariffs, resume Chinese soybean and energy imports, and keep rare-earths exports flowing Reuters. Beijing promptly agreed to suspend some counter-tariffs for a year. Yet traders remained wary.…
1 315 316 317 318 319 583

Stock Market Today

  • Four Seasons Education (NYSE:FEDU) Shares Tumble 30% Amid Mixed Growth Signals
    January 22, 2026, 6:48 AM EST. Shares of Four Seasons Education (Cayman) Inc. (NYSE:FEDU) have plunged 30% in the past month, continuing a difficult 27% decline over the last year. Despite a seemingly attractive price-to-earnings (P/E) ratio of 13.5x, below the U.S. market average of roughly 20x, the company's uneven earnings growth raises concerns. After a striking 323% earnings per share increase last year, the firm showed no growth across the past three years, suggesting inconsistent performance. This lag behind the broader market's projected 16% expansion likely explains the low P/E and wary investor sentiment. The sharp stock drop reflects caution about the company's future growth prospects, signaling that its current valuation more so captures investor apprehension than undervaluation.
Go toTop